Metraipolis › archive › dc_7e8601ca9eef

Cancer Evolvability Determines Therapy Outcomes — Europe PMC PMID:42948278

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42948278
DOI: 10.1111/eva.70320
License (as archived): solo-consultazione
Archived: 2026-10-31T07:16:09.118Z
SHA-256 of the archived text: 7425aedeec35bf170151bba70cfc9c2918d59c5476889a198c702d876ce4055c
Stable URL of this page: https://metraipolis.com/documento/dc_7e8601ca9eef

How to cite

Cancer Evolvability Determines Therapy Outcomes — Europe PMC PMID:42948278 — Europe PMC (en), https://europepmc.org/article/MED/42948278 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e8601ca9eef (Metraipolis archive dc_7e8601ca9eef, sha256 7425aedeec35bf170151bba70cfc9c2918d59c5476889a198c702d876ce4055c)

BibTeX

@misc{dc7e8601ca9eef,
  title = {Cancer Evolvability Determines Therapy Outcomes — Europe PMC PMID:42948278},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42948278},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e8601ca9eef; sha256 7425aedeec35bf170151bba70cfc9c2918d59c5476889a198c702d876ce4055c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42948278. Agents can read the archived copy with the MCP tool read_document.